GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

While worries about the affordability of care are sure to persist for many Americans over the coming year, here are some other patient payment trends for providers to watch in 2025. Growing use of ...

X4 to receive a €28.5 million upfront payment and up to €226 million in potential regulatory and commercial milestone payments in addition to ...

CNX Therapeutics Limited (“CNX Therapeutics”), a European specialty pharmaceutical company, has announced a strategic licensing deal for Sumatriptan Alginate Film, expanding its portfolio of CNS ...

Brii Biosciences Limited ("Brii Bio," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...

Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.

The UK government must prioritise patients' health over pharmaceutical profits, ensuring economic incentives don't compromise wellbeing. Robust legislation for pharmaceutical payment transparency ...

A Carroll woman has entered a plea agreement with prosecutors after taking prescription medication from patients while employed for a nursing service. According to Carroll Count District Court ...

Trinity Health of New England was still at odds in contract negotiations with health insurer Aetna just four days before the current agreement ... payment to provide the care and services patients ...